Skip to content

BIO

Bio-Rad Laboratories, Inc.

Stock

$369.14+13.57 (+3.82%)Close Oct 2, 2026

Shareholders' equity, 2025
$7.5B
YoY, 2025
+13.5%
5-year CAGR
−5.5%
10-year CAGR
+11.6%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$7.5B+13.5%
2024$6.6B−24.8%
2023$8.7B−9.1%
2022$9.6B−29.7%
2021$13.7B+38.5%
2020$9.9B+71.7%
2019$5.8B+43.1%
2018$4.0B+37.2%
2017$2.9B+13.6%
2016$2.6B+3.6%
2015$2.5B+14.0%
2014$2.2B−0.1%
2013$2.2B+8.5%
2012$2.0B+15.5%
2011$1.7B+13.5%
2010$1.5B+22.0%
2009$1.3B+17.7%
2008$1.1B—